Archivum immunologiae et therapiae experimentalis

Arch Immunol Ther Exp (Warsz) · ISSN (print) 0004-069X · 5 papers in corpus
review 2024
doi:10.2478/aite-2024-0008 ·PMID:38478380

Endometriosis is a debilitating gynecological disease defined as the presence of endometrium-like epithelium and/or stroma outside the uterine cavity. The most commonly affected sites are the pelvic peritoneum, ovaries, uterosacral ligament…

review 2017
doi:10.1007/s00005-017-0474-6 ·PMID:28523429

Reproductive failure in humans is a very important social and economic problem, because nowadays women decide to conceive later in life and delay motherhood. Unfortunately, with increasing age they have less chance for natural fertilization…

review 2008
doi:10.1007/s00005-008-0016-3 ·PMID:18373239

The role of response gene to complement (RGC)-32 as a cell cycle regulator has been attributed to its ability to activate cdc2 kinases and to induce S-phase entry and mitosis. However, recent studies revealed novel functions for RGC-32 in d…

observational 1995
·PMID:8744643

The presence of leukocyte subpopulations was demonstrated in peritoneal fluid and in endometrial tissue of women with (n = 16) and without (n = 20) endometriosis. Peritoneal fluid samples were also assayed for effects on lymphocyte prolifer…

nonrandomized-trial 1993
·PMID:8239914

Tołpa Torf Preparation (TTP) is an immunomodulating drug produced by Torf Corporation, Wrocław and registered for human use in Poland. TTP enhances the process of tissue regeneration. Authors evaluate TTP effectiveness in the treatment of i…